Head-to-head · Value Score
Ondra Health vs Aspen
Two GLP-1 deals, scored on the same six factors. Ondra Health lands a Value Score of 92, Aspen a 71. Here's who gives you the honest lower price — and where each one bites back.
Ondra Health
#2 · Grade A+ · Best Value
Est. first month
$93/mo
Save ~93% vs brand-nameAspen
#217 · Grade C · Watch List
Est. first month
From $279/mo (compounded)
Save ~79% vs brand-nameThe verdict
Ondra Health takes it on Value Score, 92 to 71 — an est. $93/mo first month, with no teaser step-up baked in. Aspen isn't out of it: Shoppers who want legitScript-certified compounded semaglutide/tirzepatide with a named accredited pharmacy and flat dosing.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Ondra Health | Aspen |
|---|---|---|
| Value Score | 92 (A+) | 71 (C) |
| Est. first month | $93/mo | From $279/mo (compounded) |
| Save vs brand-name | ~93% | ~79% |
| Semaglutide | $93/mo | From $279/mo (compounded) |
| Tirzepatide | $166/mo | From $399/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Ondra Health
The cheapest flat semaglutide sticker we track ($93) — LegitScript-certified, all 50 states, and it still offers brand-name access.
Why it's a deal
- Lowest disclosed flat semaglutide price in the roster ($93/mo) — no teaser step-up
- LegitScript-certified and available in all 50 states
- Offers FDA-approved brand-name access alongside compounded
- Tirzepatide is competitive too at $166/mo
The fine print
- Newer name with a shorter public track record than the established flat-fee brands
- No oral/sublingual route for the needle-averse
Aspen
Aspen (Aspen Health Systems LLC) is a LegitScript-certified telehealth clinic offering compounded semaglutide and tirzepatide as physician-chosen weekly injections, with flat pricing at every dose.
Why it's a deal
- LegitScript-certified with an independently verifiable seal (#50306023) and HIPAA compliance — a strong trust signal for a compounded-GLP-1 telehealth
- Names its dispensing pharmacy: Red Rock Compounding Pharmacy, LegitScript-certified and NABP-accredited, licensed in 49 states plus DC
- Flat pricing at every dose ("same price at every dose, no surprises") plus free expedited shipping, so your cost won't rise as you titrate up
- Competitive prepay rates — compounded semaglutide as low as $179/mo (12-mo) and tirzepatide $299/mo — with zero interest and no credit check
- Money-back guarantee for qualifying patients who complete the full 28-week program without losing weight; available in all 50 states + DC
The fine print
- Compounded semaglutide and tirzepatide only — no brand-name Wegovy, Zepbound or Ozempic — and compounded GLP-1s aren't FDA-reviewed or approved
- Even the "monthly" plan requires a 3-month commitment with three months of medication shipped and billed upfront — limited month-to-month flexibility
- Standing month-to-month pricing is steep ($279 semaglutide, $399 tirzepatide); the lowest rates require 6- or 12-month prepay
- The provider chooses semaglutide vs tirzepatide for you, so you can't freely pick your own molecule
- Registered as Aspen Health Systems LLC at a Sheridan, WY address; async model with no routine video visit
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Ondra Health is ranked on the Ondra Health alternatives board, and the same list for the other side is on alternatives to Aspen.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.